Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double-blind, Randomized Placebo-controlled Trial for the Preventive Effect of Limosilactobacillus Reuteri (L. Reuteri) on Excessive Crying and Colic in Healthy Infants.

NCT07347743 is registered in ClinicalTrials.gov with Universitair Ziekenhuis Brussel as lead sponsor.

NCT NCT07347743
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07347743 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double-blind, Randomized Placebo-controlled Trial for the Preventive Effect of Limosilactobacillus Reuteri (L. Reuteri) on Excessive Crying and Colic in Healthy Infants.
Lead sponsor
Universitair Ziekenhuis Brussel
Phase
Not applicable
Overall status
Recruiting
Start date
January 31, 2026
Completion date
December 31, 2028
Enrollment
768 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colic, eczema atopic dermatitis, healthy infants